Identification of genes potentially involved in LMO2-induced leukemogenesis

Leukemia

Volumn 14, Issue 11, 2000, Pages 1986-1996

  Davenport, J ^a   Neale, G A M ^a   Goorha, R ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Bub1; Cyclin D2; Hsc73; IA 2; LMO 2; Neuropilin; RDA (representational difference analysis); T cell leukemias; TRAP 230

Indexed keywords

ACUTE PHASE PROTEIN; COMPLEMENTARY DNA; CYCLIN D2; METALLOTHIONEIN; NEUROPILIN; RHOMBOTIN 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CLONE; CHILDHOOD LEUKEMIA; CHROMOSOME 11P; CONTROLLED STUDY; DNA DETERMINATION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE SEQUENCE; GENE TARGETING; HUMAN; LEUKEMIA CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; T CELL LEUKEMIA; THYMOCYTE; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

EID: 0033759380     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401913     Document Type: Article

References (48)

1. Childhood leukemias
2. Chromosomal translocations in human cancer
3. A cluster of chromosome 11p13 translocations found via distinct D-D and D-D-J arrangements of the human T cell receptor δ chain gene
4. Translocations and rearrangements in T cell acute leukemias with the t(11:14)(p13;q11) chromosomal translocation
5. Molecular cloning of the translocation breakpoint in T-ALL (11;14) (p13;q11). Genomic map of TCR-α and -β region on chromosome 14q11 and long-range map of region 11p113
6. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T cell leukemia with the t(11;14)(p13;q11)
7. Expression of the proto-oncogene rhombotin-2 is identical to the acute phase response protein metallothionein, suggesting multiple functions
8. T cell tumours of disparate phenotype in mice transgenic for Rbtn-2
9. The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice
10. - Lymphocytes in the thymus, and T cell tumors in transgenic mice
11. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development
12. T cell oncogene rhombotin-2 interacts with retinoblastoma binding protein-2 resulting in enhanced transcription
13. Association of erythroid transcription factors: Complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA 1
14. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells
15. Elf-2, a rhombotin-2 binding ets transcription factor: Discovery and potential role in T cell leukemia
16. T cell proto-oncogene rhombotin-2 is a complex transcription regulator containing multiple activation and repression domains
17. Solid-phase method for differential display of genes expressed in hematopoietic stem cells
18. Identification of target genes for the Ewing's sarcoma EWS/FL1 fusion protein by representational difference analysis
19. Identifying differences in mRNA expression by representational difference analysis of cDNA
20. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
21. Analysis of DNA sequences by blotting and hybridization
22. Expression of the V(D)J recombinase gene RAG-1 is tightly regulated and involves both transcriptional and post-translational controls
23. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FL11 fusion gene
24. Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of DNA clones from human cell line KG-1
25. IA-2, a transmembrane protein tyrosine phosphatase, is expressed in human lung cancer cell lines with neuroendocrine phenotype
26. The mouse mitotic checkpoint gene Bub1b, a novel Bub1 family member, is expressed in a cell cycle-dependent manner
27. Alterations in receptor-mediated kinases and phosphatases during carcinogenesis
28. Expression of PTP 35, the murine homologue of the protein tyrosine phosphatase - Related sequence IA-2, is regulated during cell growth and stimulated by mitogens in 3T3 fibroblasts
29. Identification of a novel gene, Vin-1, in murine leukemia virus-induced T cell leukemias by provirus insertional mutagenesis
30. The Vin-1 gene, identified by provirus insertional mutagenesis, is the cyclin D2
31. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia
32. Expression and roles of heat shock proteins in human breast cancer
33. 70-kDa heat shock cognate protein interacts directly with the N-terminal region of the retinoblastoma gene product pRb. Identification of a novel region of pRb-mediating protein interaction
34. Demonstration of selective protein complexes of p53 with 73 kDa heat shock cognate protein, but not with 72 kDa heat shock protein in human tumor cells
35. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
36. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function
37. Feedback control of mitosis in budding yeast
38. Mutations of mitotic checkpoint genes in human cancers
39. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
40. T cell-directed TAI-1 expression induces T cell malignancies in transgenic mice
41. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T cell leukemia
42. Identification of the TAL2 oncogene and its protein products
43. Structure, chromosome mapping, and expression of the mouse Ly1-1 gene
44. Thymic overexpression of Ttg-1 in transgenic mice results in T cell acute lymphoblastic leukemia/lymphoma
45. HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T cell phenotype
46. The detection of minimum residual disease in T cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse
47. Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T cell acute lymphoblastic leukemia
48. Detection of minimal residual disease in acute leukemia: Methodological advances and clinical significance